NIH to Grant Exclusive License for Virus-Like Particles for Autoantibody Induction

Summary

The National Institutes of Health is considering granting an exclusive license to practice a virus-like particle technology for inducing autoantibodies, as described in a 2001 patent application filed by Cytos Biotechnology AG.